Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? (Q44525381)
Jump to navigation
Jump to search
scientific article published in January 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? |
scientific article published in January 2003 |
Statements
1 reference
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? (English)
1 reference
Joseph Biederman
1 reference
Karen Dineen Wagner
1 reference
Graham Emslie
1 reference
Daniel A Geller
1 reference
S Evelyn Stewart
1 reference
Benjamin Mullin
1 reference
Colleen Farrell
1 reference
David Carpenter
1 reference
1 January 2003
1 reference
1 reference
13 Suppl 1
1 reference
S19-29
1 reference
Identifiers
1 reference
1 reference